San Francisco, CANCT07831317Now EnrollingIRB Ready

Gastrointestinal Discomfort Clinical Trial in San Francisco, CA

Access cutting-edge gastrointestinal discomfort treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by Daily Nouri

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access gastrointestinal discomfort specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related gastrointestinal discomfort treatment provided free

Apply for This San Francisco Location

Check if you qualify for this gastrointestinal discomfort clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Gastrointestinal Discomfort Study in San Francisco

This study looks at whether a daily probiotic supplement can help improve mild-to-moderate stomach and digestive symptoms, such as gas and bloating, in women who also experience symptoms commonly associated with hormonal fluctuations. Participants take either the probiotic or a placebo (a look-alike capsule with no active ingredients) once a day for 8 weeks, without knowing which one they are taking. Researchers will compare changes in digestive comfort, sleep, energy, and mood between the two groups over the study period. The study is conducted entirely online, so participants can take part from home.

Sponsor: Daily Nouri

Who Can Participate

Inclusion Criteria

Self-reported gas and/or bloating occurring on 4 or more days per week for at least the past 6 months
Mild-to-moderate ongoing gastrointestinal symptoms at screening, defined as a PROMIS Gastrointestinal Gas and Bloating Scale T-score of 55 to 69, inclusive
Body mass index (BMI) 18.5 to 32.5 kg/m2 (inclusive)
Self-reported symptoms of hormonal imbalance within the past 3 months, including at least one of the following: irregular or unpredictable menstrual cycles, acne, excess facial or body hair growth, or scalp hair thinning
If using psychotropic medication (including antidepressants, anxiolytics, mood stabilizers, or stimulants): stable medication and dose for at least three months prior to screening, with no anticipated changes during the study; medication name, dose, and start date recorded at screening
If using hormonal contraception: stable method for at least three months prior to screening, with no anticipated changes during the study; method and start date recorded at screening
Willing to abstain from all other probiotic and prebiotic supplements and probiotic-fortified functional foods from screening through study completion
Willing and able to maintain consistent diet, physical activity, and medication habits for the duration of the study
Willing and able to provide electronic informed consent and comply with the protocol
Resident of the United States with access to a smartphone with internet access and a functioning front-facing or rear camera, to allow completion of all online instruments and the skin health selfie assessment
Able to read and understand English at the 6th-grade level

Exclusion Criteria

Current use of a GLP-1 receptor agonist of any class or type, or use within the 3 months prior to screening
Use of any probiotic or prebiotic dietary supplement within the 4 weeks prior to screening
Use of systemic antibiotics within the 4 weeks prior to screening, or anticipated use during the study
Diagnosed gastrointestinal disease or disorder, including inflammatory bowel disease (Crohn's disease, ulcerative colitis), celiac disease, gastroparesis, gastrointestinal malignancy, or prior bariatric or other major gastrointestinal surgery
Current or past diagnosis of endometriosis or a thyroid or other endocrine/gynecological disorder, whether or not currently controlled
Chronic or serious medical conditions, including uncontrolled cardiovascular, metabolic, neurologic, immune (including immunocompromised states), renal, or hepatic disease, or any medical condition deemed exclusionary by the Principal Investigator
Current or past diagnosis of bipolar I/II disorder, schizophrenia spectrum or other psychotic disorder; psychiatric hospitalization, suicidal ideation, suicide attempt, or self-harm behavior in the past 12 months
Initiation, discontinuation, or dose change of any psychotropic medication within the 3 months prior to screening
Allergy or sensitivity to any ingredient in the study product
History of drug or alcohol abuse in the past 12 months
Currently pregnant, breastfeeding, or planning to become pregnant during the study period
Participation in another interventional research study within 30 days prior to screening that could confound the outcomes of this study
Currently in prison, in custody, or otherwise a ward of the state

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT07831317) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gastrointestinal Discomfort Treatment Options in San Francisco, CA

If you're searching for gastrointestinal discomfort treatment options in San Francisco, CA, this clinical trial (NCT07831317) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastrointestinal discomfort specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gastrointestinal discomfort clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in San Francisco, CA

See all ankylosing spondylitis clinical trials recruiting in San Francisco — not just this study.

Browse Ankylosing Spondylitis Trials in San Francisco →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsGeographic Atrophy TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA